Global Cardiac Biomarkers Market Insights, Forecast to 2025

Publisher Name :
Date: 10-Jun-2019
No. of pages: 116
Inquire Before Buying

Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These are specifically used to check the presence or severity of cardiovascular diseases. Cardiac biomarkers are the substances that are released into blood when heart is damaged. These biomarkers are also used for diagnosing and monitoring diseases such as coronary syndrome or cardiac ischemia. The symptoms of these diseases includes chest pain, shortness of breath and nausea that ultimately leads to heart attack or angina. Cardiac biomarker tests helps to detect presence of coronary syndrome and cardiac ischemia to evaluate its severity and diagnosis.

The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. Cardiac biomarkers market has witnessed a greater demand over the past five to six years. 

There is a high demand for cardiac biomarkers due to their proficiency and the ability to provide accurate results. The number of clinical trials conducted for cardiac biomarkers is steadily increasing since manufactures, universities, and research institutes are focused on improving the efficiency and efficacy of the biomarkers. Cardiac biomarker manufacturers are increasingly focusing on R&D to perform several clinical trials to prove the effectiveness of the products and increase their consumer base. According to our industry research and analysis, the increase in number of clinical trials will be one of the key trends that will gain traction in the cardiac biomarkers market during the next few years.

North America leads the global market, owing to the high demand for cardiac testing, high CVD prevalence rate and growing awareness towards cardiac diagnostics solutions. Asia-Pacific is growing at the fastest CAGR due to the modernization, increasing disposable incomes and rising affordability for the advanced cardiac treatments.

The global Cardiac Biomarkers market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cardiac Biomarkers market based on company, product type, end user and key regions.

This report studies the global market size of Cardiac Biomarkers in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiac Biomarkers in these regions.

This research report categorizes the global Cardiac Biomarkers market by top players/brands, region, type and end user. This report also studies the global Cardiac Biomarkers market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Abbott

- Alere

- F. Hoffmann-La Roche

- Advanced ImmunoChemical

- AgPlus Diagnostics

- BG Medicine

- BioLegend

- bioMérieux

- Bio-Rad Laboratories

- BODITECH MED

Market size by Product

- Troponin

- CK-MB

- Natriuretic Peptides - BNP and NT-proBNP

- Myoglobin

- Others

Market size by End User

- Acute Coronary Syndrome

- Myocardial Infarction

- Congestive Heart Failure

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Cardiac Biomarkers market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Cardiac Biomarkers market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Cardiac Biomarkers companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Cardiac Biomarkers submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Cardiac Biomarkers are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cardiac Biomarkers market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Cardiac Biomarkers Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Cardiac Biomarkers Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Cardiac Biomarkers Market Size Growth Rate by Product
1.4.2 Troponin
1.4.3 CK-MB
1.4.4 Natriuretic Peptides - BNP and NT-proBNP
1.4.5 Myoglobin
1.4.6 Others
1.5 Market by End User
1.5.1 Global Cardiac Biomarkers Market Size Growth Rate by End User
1.5.2 Acute Coronary Syndrome
1.5.3 Myocardial Infarction
1.5.4 Congestive Heart Failure
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cardiac Biomarkers Market Size
2.1.1 Global Cardiac Biomarkers Revenue 2014-2025
2.1.2 Global Cardiac Biomarkers Sales 2014-2025
2.2 Cardiac Biomarkers Growth Rate by Regions
2.2.1 Global Cardiac Biomarkers Sales by Regions
2.2.2 Global Cardiac Biomarkers Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Cardiac Biomarkers Sales by Manufacturers
3.1.1 Cardiac Biomarkers Sales by Manufacturers
3.1.2 Cardiac Biomarkers Sales Market Share by Manufacturers
3.1.3 Global Cardiac Biomarkers Market Concentration Ratio (CR5 and HHI)
3.2 Cardiac Biomarkers Revenue by Manufacturers
3.2.1 Cardiac Biomarkers Revenue by Manufacturers (2014-2019)
3.2.2 Cardiac Biomarkers Revenue Share by Manufacturers (2014-2019)
3.3 Cardiac Biomarkers Price by Manufacturers
3.4 Cardiac Biomarkers Manufacturing Base Distribution, Product Types
3.4.1 Cardiac Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cardiac Biomarkers Product Type
3.4.3 Date of International Manufacturers Enter into Cardiac Biomarkers Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Cardiac Biomarkers Sales by Product
4.2 Global Cardiac Biomarkers Revenue by Product
4.3 Cardiac Biomarkers Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Cardiac Biomarkers Breakdown Data by End User
6 North America
6.1 North America Cardiac Biomarkers by Countries
6.1.1 North America Cardiac Biomarkers Sales by Countries
6.1.2 North America Cardiac Biomarkers Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Cardiac Biomarkers by Product
6.3 North America Cardiac Biomarkers by End User
7 Europe
7.1 Europe Cardiac Biomarkers by Countries
7.1.1 Europe Cardiac Biomarkers Sales by Countries
7.1.2 Europe Cardiac Biomarkers Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cardiac Biomarkers by Product
7.3 Europe Cardiac Biomarkers by End User
8 Asia Pacific
8.1 Asia Pacific Cardiac Biomarkers by Countries
8.1.1 Asia Pacific Cardiac Biomarkers Sales by Countries
8.1.2 Asia Pacific Cardiac Biomarkers Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Cardiac Biomarkers by Product
8.3 Asia Pacific Cardiac Biomarkers by End User
9 Central & South America
9.1 Central & South America Cardiac Biomarkers by Countries
9.1.1 Central & South America Cardiac Biomarkers Sales by Countries
9.1.2 Central & South America Cardiac Biomarkers Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Cardiac Biomarkers by Product
9.3 Central & South America Cardiac Biomarkers by End User
10 Middle East and Africa
10.1 Middle East and Africa Cardiac Biomarkers by Countries
10.1.1 Middle East and Africa Cardiac Biomarkers Sales by Countries
10.1.2 Middle East and Africa Cardiac Biomarkers Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Cardiac Biomarkers by Product
10.3 Middle East and Africa Cardiac Biomarkers by End User
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Company Business Overview
11.1.3 Abbott Cardiac Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbott Cardiac Biomarkers Products Offered
11.1.5 Abbott Recent Development
11.2 Alere
11.2.1 Alere Company Details
11.2.2 Company Business Overview
11.2.3 Alere Cardiac Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Alere Cardiac Biomarkers Products Offered
11.2.5 Alere Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 Company Business Overview
11.3.3 F. Hoffmann-La Roche Cardiac Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.3.4 F. Hoffmann-La Roche Cardiac Biomarkers Products Offered
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Advanced ImmunoChemical
11.4.1 Advanced ImmunoChemical Company Details
11.4.2 Company Business Overview
11.4.3 Advanced ImmunoChemical Cardiac Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Advanced ImmunoChemical Cardiac Biomarkers Products Offered
11.4.5 Advanced ImmunoChemical Recent Development
11.5 AgPlus Diagnostics
11.5.1 AgPlus Diagnostics Company Details
11.5.2 Company Business Overview
11.5.3 AgPlus Diagnostics Cardiac Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.5.4 AgPlus Diagnostics Cardiac Biomarkers Products Offered
11.5.5 AgPlus Diagnostics Recent Development
11.6 BG Medicine
11.6.1 BG Medicine Company Details
11.6.2 Company Business Overview
11.6.3 BG Medicine Cardiac Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.6.4 BG Medicine Cardiac Biomarkers Products Offered
11.6.5 BG Medicine Recent Development
11.7 BioLegend
11.7.1 BioLegend Company Details
11.7.2 Company Business Overview
11.7.3 BioLegend Cardiac Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.7.4 BioLegend Cardiac Biomarkers Products Offered
11.7.5 BioLegend Recent Development
11.8 bioMérieux
11.8.1 bioMérieux Company Details
11.8.2 Company Business Overview
11.8.3 bioMérieux Cardiac Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.8.4 bioMérieux Cardiac Biomarkers Products Offered
11.8.5 bioMérieux Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Company Business Overview
11.9.3 Bio-Rad Laboratories Cardiac Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Bio-Rad Laboratories Cardiac Biomarkers Products Offered
11.9.5 Bio-Rad Laboratories Recent Development
11.10 BODITECH MED
11.10.1 BODITECH MED Company Details
11.10.2 Company Business Overview
11.10.3 BODITECH MED Cardiac Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.10.4 BODITECH MED Cardiac Biomarkers Products Offered
11.10.5 BODITECH MED Recent Development
12 Future Forecast
12.1 Cardiac Biomarkers Market Forecast by Regions
12.1.1 Global Cardiac Biomarkers Sales Forecast by Regions 2019-2025
12.1.2 Global Cardiac Biomarkers Revenue Forecast by Regions 2019-2025
12.2 Cardiac Biomarkers Market Forecast by Product
12.2.1 Global Cardiac Biomarkers Sales Forecast by Product 2019-2025
12.2.2 Global Cardiac Biomarkers Revenue Forecast by Product 2019-2025
12.3 Cardiac Biomarkers Market Forecast by End User
12.4 North America Cardiac Biomarkers Forecast
12.5 Europe Cardiac Biomarkers Forecast
12.6 Asia Pacific Cardiac Biomarkers Forecast
12.7 Central & South America Cardiac Biomarkers Forecast
12.8 Middle East and Africa Cardiac Biomarkers Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cardiac Biomarkers Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Cardiac Biomarkers Product Picture
Table Cardiac Biomarkers Market Segments
Table Key Manufacturers Cardiac Biomarkers Covered
Table Global Cardiac Biomarkers Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Cardiac Biomarkers Sales Market Share by Product 2014-2025
Figure Troponin Product Picture
Table Major Manufacturers of Troponin
Figure CK-MB Product Picture
Table Major Manufacturers of CK-MB
Figure Natriuretic Peptides - BNP and NT-proBNP Product Picture
Table Major Manufacturers of Natriuretic Peptides - BNP and NT-proBNP
Figure Myoglobin Product Picture
Table Major Manufacturers of Myoglobin
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Cardiac Biomarkers Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Acute Coronary Syndrome
Figure Myocardial Infarction
Figure Congestive Heart Failure
Figure Others
Figure Cardiac Biomarkers Report Years Considered
Figure Global Cardiac Biomarkers Market Size 2014-2025 (Million US$)
Figure Global Cardiac Biomarkers Sales 2014-2025 (K Units)
Table Global Cardiac Biomarkers Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Cardiac Biomarkers Sales by Regions 2014-2019 (K Units)
Table Global Cardiac Biomarkers Sales Market Share by Regions 2014-2019
Figure Global Cardiac Biomarkers Sales Market Share by Regions 2014-2019
Figure 2018 Global Cardiac Biomarkers Sales Market Share by Regions
Table Global Cardiac Biomarkers Revenue by Regions 2014-2019 (Million US$)
Table Global Cardiac Biomarkers Revenue Market Share by Regions 2014-2019
Figure Global Cardiac Biomarkers Revenue Market Share by Regions 2014-2019
Figure 2018 Global Cardiac Biomarkers Revenue Market Share by Regions
Table Global Cardiac Biomarkers Sales by Manufacturers (2014-2019) (K Units)
Table Global Cardiac Biomarkers Sales Share by Manufacturers (2014-2019)
Figure Global Cardiac Biomarkers Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Cardiac Biomarkers Revenue by Manufacturers (2014-2019) (Million USD)
Table Cardiac Biomarkers Revenue Share by Manufacturers (2014-2019)
Figure Cardiac Biomarkers Value Share by Manufacturers in 2018
Table Key Manufacturers Cardiac Biomarkers Price (2014-2019) (USD/Unit)
Table Cardiac Biomarkers Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Cardiac Biomarkers Product Type
Table Date of International Manufacturers Enter into Cardiac Biomarkers Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Cardiac Biomarkers Sales by Product (2014-2019) (K Units)
Table Global Cardiac Biomarkers Sales Share by Product (2014-2019)
Figure Global Cardiac Biomarkers Sales Market Share by Product (2014-2019)
Figure Global Cardiac Biomarkers Sales Market Share by Product in 2018
Table Global Cardiac Biomarkers Revenue by Product (2014-2019) (Million US$)
Table Global Cardiac Biomarkers Revenue Share by Product (2014-2019)
Figure Global Cardiac Biomarkers Revenue Market Share by Product (2014-2019)
Figure Global Cardiac Biomarkers Revenue Market Share by Product in 2018
Table Cardiac Biomarkers Price by Product 2014-2019 (USD/Unit)
Table Global Cardiac Biomarkers Sales by End User (2014-2019) (K Units)
Table Global Cardiac Biomarkers Sales Share by End User (2014-2019)
Figure Global Sales Cardiac Biomarkers Market Share by End User (2014-2019)
Figure Global Sales Cardiac Biomarkers Market Share by End User in 2018
Figure North America Cardiac Biomarkers Sales Growth Rate 2014-2019 (K Units)
Figure North America Cardiac Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
Table North America Cardiac Biomarkers Sales by Countries (2014-2019) (K Units)
Table North America Cardiac Biomarkers Sales Market Share by Countries (2014-2019)
Figure 2018 North America Cardiac Biomarkers Sales Market Share by Countries
Table North America Cardiac Biomarkers Revenue by Countries (2014-2019) (Million US$)
Table North America Cardiac Biomarkers Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Cardiac Biomarkers Revenue Market Share by Countries
Figure United States Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure United States Cardiac Biomarkers Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Canada Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Table North America Cardiac Biomarkers Sales by Product (2014-2019) (K Units)
Table North America Cardiac Biomarkers Sales Market Share by Product (2014-2019)
Figure 2018 North America Cardiac Biomarkers Market Share by Product
Table North America Cardiac Biomarkers Sales by End User (2014-2019) (K Units)
Table North America Cardiac Biomarkers Sales Market Share by End User (2014-2019)
Figure 2018 North America Cardiac Biomarkers Market Share by End User
Figure Europe Cardiac Biomarkers Sales Growth Rate 2014-2019 (K Units)
Figure Europe Cardiac Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Cardiac Biomarkers Sales by Countries (2014-2019) (K Units)
Table Europe Cardiac Biomarkers Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Cardiac Biomarkers Sales Market Share by Countries
Table Europe Cardiac Biomarkers Revenue by Countries (2014-2019) (Million US$)
Table Europe Cardiac Biomarkers Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Cardiac Biomarkers Revenue Market Share by Countries
Figure Germany Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Germany Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure France Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure France Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure UK Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Italy Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Russia Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Cardiac Biomarkers Sales by Product (2014-2019) (K Units)
Table Europe Cardiac Biomarkers Sales Market Share by Product (2014-2019)
Figure 2018 Europe Cardiac Biomarkers Market Share by Product
Table Europe Cardiac Biomarkers Sales by End User (2014-2019) (K Units)
Table Europe Cardiac Biomarkers Sales Market Share by End User (2014-2019)
Figure 2018 Europe Cardiac Biomarkers Market Share by End User
Figure Asia Pacific Cardiac Biomarkers Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Cardiac Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Cardiac Biomarkers Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Cardiac Biomarkers Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cardiac Biomarkers Sales Market Share by Countries
Table Asia Pacific Cardiac Biomarkers Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Cardiac Biomarkers Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cardiac Biomarkers Revenue Market Share by Countries
Figure China Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure China Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Japan Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Korea Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure India Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure India Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Australia Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Cardiac Biomarkers Sales by Product (2014-2019) (K Units)
Table Asia Pacific Cardiac Biomarkers Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Cardiac Biomarkers Market Share by Product
Table Asia Pacific Cardiac Biomarkers Sales by End User (2014-2019) (K Units)
Table Asia Pacific Cardiac Biomarkers Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Cardiac Biomarkers Market Share by End User
Figure Central & South America Cardiac Biomarkers Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Cardiac Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Cardiac Biomarkers Sales by Countries (2014-2019) (K Units)
Table Central & South America Cardiac Biomarkers Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cardiac Biomarkers Sales Market Share by Countries
Table Central & South America Cardiac Biomarkers Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Cardiac Biomarkers Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cardiac Biomarkers Revenue Market Share by Countries
Figure Brazil Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Cardiac Biomarkers Sales by Product (2014-2019) (K Units)
Table Central & South America Cardiac Biomarkers Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Cardiac Biomarkers Market Share by Product
Table Central & South America Cardiac Biomarkers Sales by End User (2014-2019) (K Units)
Table Central & South America Cardiac Biomarkers Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Cardiac Biomarkers Market Share by End User
Figure Middle East and Africa Cardiac Biomarkers Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Cardiac Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Cardiac Biomarkers Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Cardiac Biomarkers Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cardiac Biomarkers Sales Market Share by Countries
Table Middle East and Africa Cardiac Biomarkers Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Cardiac Biomarkers Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cardiac Biomarkers Revenue Market Share by Countries
Figure GCC Countries Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Cardiac Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Cardiac Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Cardiac Biomarkers Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Cardiac Biomarkers Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Cardiac Biomarkers Market Share by Product
Table Middle East and Africa Cardiac Biomarkers Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Cardiac Biomarkers Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Cardiac Biomarkers Market Share by End User
Table Abbott Company Details
Table Abbott Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Recent Development
Table Alere Company Details
Table Alere Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Alere Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Advanced ImmunoChemical Company Details
Table Advanced ImmunoChemical Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Advanced ImmunoChemical Recent Development
Table AgPlus Diagnostics Company Details
Table AgPlus Diagnostics Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AgPlus Diagnostics Recent Development
Table BG Medicine Company Details
Table BG Medicine Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BG Medicine Recent Development
Table BioLegend Company Details
Table BioLegend Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BioLegend Recent Development
Table bioMérieux Company Details
Table bioMérieux Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table bioMérieux Recent Development
Table Bio-Rad Laboratories Company Details
Table Bio-Rad Laboratories Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bio-Rad Laboratories Recent Development
Table BODITECH MED Company Details
Table BODITECH MED Cardiac Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BODITECH MED Recent Development
Table Global Cardiac Biomarkers Sales Forecast by Regions 2019-2025 (K Units)
Table Global Cardiac Biomarkers Sales Market Share Forecast by Regions 2019-2025
Table Global Cardiac Biomarkers Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Cardiac Biomarkers Revenue Market Share Forecast by Regions 2019-2025
Table Global Cardiac Biomarkers Sales Forecast by Product 2019-2025 (K Units)
Table Global Cardiac Biomarkers Sales Market Share Forecast by Product 2019-2025
Table Global Cardiac Biomarkers Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Cardiac Biomarkers Revenue Market Share Forecast by Product 2019-2025
Table Global Cardiac Biomarkers Sales Forecast by End User 2019-2025 (K Units)
Table Global Cardiac Biomarkers Sales Market Share Forecast by End User 2019-2025
Figure North America Cardiac Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Cardiac Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Cardiac Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Cardiac Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Cardiac Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Cardiac Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Cardiac Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Cardiac Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Cardiac Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Cardiac Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Cardiac Biomarkers Value Chain
Table Cardiac Biomarkers Customers List
Table Cardiac Biomarkers Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Biomarkers Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biomarkers market size was valued at US$ 61570 million in 2023. With growing demand in downstream market, the Biomarkers is forecast to a readjusted size of US$ 165240 million by 2030 with a CAGR of 15.1% during review period. The research report highlights the growth potential of the global Biomarkers market. Biomarkers are expected to show stable growth in the future market. However, product differentiation, reducing costs,......
  • Global Biomarker (Medicine) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Biomarker (Medicine) market: According to our latest research, the global Biomarker (Medicine) market looks promising in the next 5 years. As of 2022, the global Biomarker (Medicine) market was estimated at USD 54332.95 million, and it's anticipated to reach USD 82760.29 million in 2028, with a CAGR of 7.27% during the forecast years. Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker i......
  • Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size was valued at US$ 20920 million in 2023. With growing demand in downstream market, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications is forecast to a readjusted size of US$ 29400 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Commercializing Biom......
  • Global Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Biomarkers market: According to our latest research, the global Biomarkers market looks promising in the next 5 years. As of 2022, the global Biomarkers market was estimated at USD 76755.97 million, and it's anticipated to reach USD 184776.75 million in 2028, with a CAGR of 15.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biomarkers market, with a......
  • Global Biomarker Technology Market Research Report 2023
    Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 86
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biomarker Technology market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - Quanterix - Bio-Rad Laboratories - Epigenomics - Agilent Technologies - Johnson & Johnson - Qiagen - Roche Ho......
  • Global Renal Biomarkers Market Research Report 2023
    Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 99
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Renal Biomarkers market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Diagnostics - F. Hoffmann-La Roche - Beckman Coulter - Siemens Healthcare Diagnostics - Thermo Fisher Scientific - Astute Medical - Bio......
  • Global Central Nervous System (CNS) Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Central Nervous System (CNS) Biomarkers market: According to our latest research, the global Central Nervous System (CNS) Biomarkers market looks promising in the next 5 years. As of 2022, the global Central Nervous System (CNS) Biomarkers market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. An overview of the global market for central nervous system (CNS) biomarke......
  • Global Cancer Biomarker Market Research Report 2023
    Published: 13-Nov-2023        Price: US 2900 Onwards        Pages: 109
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Biomarker market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Thermo Fisher Scientific - Bio-Rad Laboratories - Roche Diagnostics - Qiagen - Illumina - GE Healthcare - Agilent Technologies - Biomér......
  • Biomarker Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300
    Biomarker Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the biomarker deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of biomarker deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter biomarker deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercializ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs